The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Viking Therapeutics, Inc(NASDAQ:VKTX)


Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TR), ...
Website: http://www.vikingtherapeutics.com
Founded: 2012
Full Time Employees: 17
Sector: Healthcare
Industry: Biotechnology
Viking Therapeutics Days Payable Outstanding ttm (DPO)
Viking Therapeutics Op Cashflow Per Share ttm
Viking Therapeutics Free Cashflow Per Share ttm
Viking Therapeutics Cash Per Share ttm
Viking Therapeutics P/S ratio ttm
Viking Therapeutics (GAAP) P/E ratio ttm
Viking Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.